Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.
Ariano, R., Incorvaia, C., La Grutta, S., Marcucci, F., Pajno, G., Sensi, L., et al. (2009). Safety of sublingual immunotherapy started during the pollen season. CURRENT MEDICAL RESEARCH AND OPINION, 25(1), 103-107 [10.1185/03007990802591673].
Safety of sublingual immunotherapy started during the pollen season
LA GRUTTA, Stefania;
2009-01-01
Abstract
Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
(30) Ariano_CMRO_2009_Safety of SLIT.pdf
accesso aperto
Dimensione
77.74 kB
Formato
Adobe PDF
|
77.74 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
